Thursday, December 13, 2018 2:07:35 PM
There's still a little bit left to prove that their system is viable. If we can cross over that point, the stock is going to go up ten fold or more. I believe we'll have the absolute answer to that by the end of Q1 2019. Possible setbacks would be they halt mass production/installation based on what they find with the first 5-10 installs to make improvements. We know that several generations from now the product will be better, but they HAVE to nail this first commercial version to warrant future versions.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM